|
NKX019 Clinical Trials
2 actively recruiting trials across 2 locations
Also known as: NKX019 infusion
Little Rock, Arkansas1 trial
A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)
Nkarta Investigational Site
Phase 1/2
New York, New York1 trial
A Study of NKX019, a CD19 CAR NK Cell Therapy, in Subjects With Systemic Lupus Erythematosus
Columbia University Irving Medical Center
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.